Over 50 Years of
Building long-lasting relationships with pharmacists and compounding professionals to deliver high-quality, high-value, devices to advance the safety and security of your drugs, practitioners and patients.
Industry leading Drug Security
For 50 years, IMI has worked closely with pharmacists and compounding professionals to create innovative, American made, sterile devices that meet very specialized needs. Throughout this time, IMI has established long-standing partnerships with some of the biggest names in healthcare. Through these partnerships and directly, IMI is delivering the kind of high-quality and high-value products that pharmacy operations demand.
At the core of IMI’s product line, you will find our unique tamper evident technologies. These products offer an active deterrent to potential drug diversion and misuse. Our tamper evident products are an important component of a health system’s total drug security program.
- IMI Products are Manufactured in the USA
- ISO 8 Cleanroom Controlled Environment
- FDA registered and compliant to quality system regulations
IMI strives to deliver innovative and timely medical devices, designed to enhance your drug security programs. We are your dedicated partner in secure drug delivery devices. Our constant commitment to pharmacists and compounding professionals within the healthcare industry guarantees superior support in addition to the high-quality, high-value products your operations demand. In fostering an environment that rewards innovation, education, and devotion to customer satisfaction, we will remain your trusted source for industry-leading devices that enhance security and efficiency.
IMI EXECUTIVE TEAM
Jon Vitello has over 30 years of progressive management experience, including key product development roles with IBM. His acquisition of IMI in 1993 had an immediate and positive impact on the direction of the organization . As a strategist and accessible leader, Jon is known for driving GROWTH AND PROFITABILITY with expertise developing and delivering technology solutions for hospitals, health systems and drug compounding outsourcers.
Senior Vice President, Operations
Susan Vitello is a seasoned business professional who has managed most of IMI’s key functions at various times during her tenure. Her strong management and relationship skills have driven customer satisfaction levels by delivering clear communications and championing the “voice of the customer” throughout the organization. Susan’s wealth of experience has proven invaluable in her current role overseeing the finance and business operations teams.
Bryan McGurn has over 30 years’ experience in the medical device field. Prior to his position as VP Sales & Marketing, Bryan held a number of key roles in executive and general management with P&L responsibility. Throughout his career, he has made a mark in orchestrating countless revenue generating sales programs and marketing campaigns that clearly articulate product benefits and organizational strengths. His previous management tenures include companies such as American Hydro-Surgical, Nipro Corporation, and Medtronic MiniMed.
Chief Financial Officer
Virginia Mateo has over 20 years of robust experience in financial portfolio management. She has a proven track record of creating and implementing corporate practices and policies that consistently generate profitable results. Over the years, she has successfully executed her operational decision-making prowess to bring financial gains to firms from the hospitality, real estate, and entertainment sectors. Virginia is an accredited, detail orientated leader with a noteworthy history of harmonizing legal, insurance, finance, and sales teams around best practices to ensure the organization’s long-term health.
Vice President, Quality Assurance & Regulatory Affairs
David Meily joined IMI in April 2019, bringing more than 20 years of Quality and Regulatory leadership experience in medical devices. Throughout his career, he enjoyed success in transforming quality culture, change management, and continuous improvement. His considerable QA/RA talents have guided companies like Stryker, Terumo, and Aquabiliti. Dave is noted for his professionalism, knowledge, and ability to navigate successfully in the complex quality and regulatory world of medical devices.
Vice President, Sales & Business Development
Tony Delemaza brings over 25 years of experience in the fields of medical device, biologics and cellular therapy to IMI. Prior to joining the team as the VP of Sales & Business development, he held various positions in general and executive management with multi-national companies including DaVinci Biosciences, Nipro Corporation, and Medtronic MiniMed. Tony is an accomplished leader with expertise in developing Sales, Clinical, and Customer Service teams to drive revenue growth while introducing state-of-the-art therapies to enhance clinical outcomes.